Multi-attribute method based characterization of antibody drug conjugates (ADC) at the intact and subunit levels
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 201, 114094
Abstract
No abstract availableKeywords
Funding Information
- AB Sciex Sales LP
This publication has 36 references indexed in Scilit:
- Multi-Attribute Method for Quality Control of Therapeutic ProteinsAnalytical Chemistry, 2019
- Antibody–drug conjugates for cancerThe Lancet, 2019
- Expanding the Boundaries of Biotherapeutics with Bispecific AntibodiesBioDrugs, 2018
- A View on the Importance of “Multi-Attribute Method” for Measuring Purity of Biopharmaceuticals and Improving Overall Control StrategyThe AAPS Journal, 2017
- The making of bispecific antibodiesmAbs, 2016
- Antibody-drug conjugates: recent advances in conjugation and linker chemistriesProtein & Cell, 2016
- Determination of critical quality attributes for monoclonal antibodies using quality by design principlesBiologicals, 2016
- Alternative molecular formats and therapeutic applications for bispecific antibodiesMolecular Immunology, 2015
- Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologicsmAbs, 2015
- A new tool for monoclonal antibody analysismAbs, 2014